Cyclophosphamide pulse therapy in systemic lupus erythematosus
Ichikawa, Y.; Yamada, H.; Tanaka, H.; Yoshida, T.
Ryumachi 34(3): 675-683
1994
ISSN/ISBN: 0300-9157 PMID: 8052935 Document Number: 438923
Document emailed within 1 workday
Related Documents
Yang, X.; Yin, P.; Gao, X. 1996: A study on interval of intravenous cyclophosphamide pulse in the treatment of severe systemic lupus erythematosus Zhonghua Nei Ke Za Zhi 35(4): 257-260Kinashi, M.; Kurata, N.; Hara, I.; Akita, H.; Ofuji, T. 1981: Effects of pulse therapy on renal insufficiency of systemic lupus erythematosus Nihon Jinzo Gakkai Shi 23(1): 35-44
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Gallo, M.; La Montagna, G.; Chianese, U.; Tirri, R.; Tirri, G. 1992: Methylprednisolone pulse therapy as primary management strategy in systemic lupus erythematosus Journal of Rheumatology 19(8): 1322-1323
Aikawa, N.E.; Sallum, A.M.E.; Pereira, R.M.R.; Suzuki, L.; Viana, V.S.T.; Bonfá, E.; Silva, C.A. 2012: Subclinical impairment of ovarian reserve in juvenile systemic lupus erythematosus after cyclophosphamide therapy Clinical and Experimental Rheumatology 30(3): 445-449
Yang, X.-y.; Zhu, X.; Liang, L.-q.; Zhan, Z.-p.; Ye, Y.-j. 2005: Risk factors of ovarian failure in the patients with systemic lupus erythematosus receiving cyclophosphamide therapy Zhonghua Yi Xue Za Zhi 85(14): 960-962
Mittal, G.; Balakrishnan, C.; Mangat, G.; Joshi, V.R. 1999: High dose cyclophosphamide in the treatment of systemic lupus erythematosus Journal of the Association of Physicians of India 47(7): 747
Anić, B.; Crkvencić, N.; Mayer, M.; Bosnić, D.; Sentić, M.; Markeljević, J.; Cikes, N. 1999: Intermittent intravenous cyclophosphamide application in patients with systemic lupus erythematosus Lijecnicki Vjesnik 121(9-10): 283-288
Fuks, A.; Carballal, G.; Manni, J.A. 1979: Immunosuppression in systemic lupus erythematosus. Effect of cyclophosphamide and corticoids on lymphocyte subpopulations Medicina 39(3): 289-297
Carr, R.; Forsyth, S.; Sadi, D. 1987: Abnormal responses to ingested substances in murine systemic lupus erythematosus: apparent effect of a casein-free diet on the development of systemic lupus erythematosus in NZB/W mice Journal of Rheumatology. Suppl 14(Suppl 13): 158-165
Groen, H.; Bootsma, H.; Postma, D.S.; Kallenberg, C.G. 1993: Primary pulmonary hypertension in a patient with systemic lupus erythematosus: partial improvement with cyclophosphamide Journal of Rheumatology 20(6): 1055-1057
Iwata, N.; Miyamae, T.; Imagawa, T.; Katakura, S.; Mori, M.; Aihara, Y.; Yokota, S.; Kondo, M.; Sasaki, T.; Ikezawa, Y. 2003: Cyclophosphamide pulse therapy for pediatric systemic sclerosis Ryumachi 43(4): 660-666
Leung, F.K.; Fortin, P.R. 2003: Intravenous cyclophosphamide and high dose corticosteroids improve MRi lesions in demyelinating syndrome in systemic lupus erythematosus Journal of Rheumatology 30(8): 1871-1873
Yan, D.C.; Chou, C.C.; Tsai, M.J.; Chiang, B.L.; Tsau, Y.K.; Hsieh, K.H. 1995: Intravenous cyclophosphamide pulse therapy on children with severe active lupus nephritis Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi Zhonghua Minguo Xiao Er Ke Yi Xue Hui 36(3): 203-209
Barbano, G.; Gusmano, R.; Damasio, B.; Alpigiani, M.Giannina.; Buoncompagni, A.; Gattorno, M.; Perfumo, F. 2002: Childhood-onset lupus nephritis: a single-center experience of pulse intravenous cyclophosphamide therapy Journal of Nephrology 15(2): 123-129
Hossain, M.B.; Khan, M.F.; Ansary, E.F.; Mamun, A.A.; Talukder, F.A.; Hasan, R.; Chowdhury, M.N.; Islam, M.N.; Gupta, R.D.; Ahmed, P.I.; Bhuiyan, F.K.; Roy, A.S.; Ahammed, S.U.; Asadujjaman, M.; Rahman, M.A.; Robbani, M.G.; Talukder, R.K.; Borman, G.C.; Sarker, N.R.; Khan, S.I.; Roy, P.P. 2018: Response of Proliferative Lupus Nephritis with Pulse Cyclophosphamide Therapy during Induction Period: a Single Centre Study in Bangladesh Mymensingh Medical Journal: Mmj 27(4): 693-701
Taylor, J.K.; McMurray, R.V. 2011: Medical therapy for systemic lupus erythematosus Journal of the Mississippi State Medical Association 52(2): 39-43
Spertini, F.ço. 2007: New concepts for the therapy of systemic lupus erythematosus Revue Medicale Suisse 3(94): 98-102
Maksimov, A.A.; Shaĭkov, A.V.; Speranskiĭ, A.I.; Solov'ev, S.K. 1992: Pulse therapy with methylprednisolone and cyclophosphamide in systemic juvenile rheumatoid arthritis: the results of an open, parallel, controlled, randomized, 12-month study Terapevticheskii Arkhiv 64(5): 47-51
Stevens, M.B. 1984: Systemic lupus erythematosus XII: Cytotoxic therapy and pheresis Maryland State Medical Journal 33(7): 538-540